User menu

Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice

Bibliographic reference Bindels, Laure B. ; Neyrinck, Audrey M. ; Salazar Garzo, Nuria ; Taminiau, Bernard ; Druart, Céline ; et. al. Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice. In: PLoS One, Vol. 10, no. 6, p. e0131009 [1-16] (2015)
Permanent URL
  1. MJ Claesson, Nature, 488, 178 (2012)
  2. Koren Omry, Goodrich Julia K., Cullender Tyler C., Spor Aymé, Laitinen Kirsi, Kling Bäckhed Helene, Gonzalez Antonio, Werner Jeffrey J., Angenent Largus T., Knight Rob, Bäckhed Fredrik, Isolauri Erika, Salminen Seppo, Ley Ruth E., Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy, 10.1016/j.cell.2012.07.008
  3. LB Bindels, Nat Rev Gastroenterol Hepatol (2015)
  4. Roberfroid Marcel, Gibson Glenn R., Hoyles Lesley, McCartney Anne L., Rastall Robert, Rowland Ian, Wolvers Danielle, Watzl Bernhard, Szajewska Hania, Stahl Bernd, Guarner Francisco, Respondek Frederique, Whelan Kevin, Coxam Veronique, Davicco Marie-Jeanne, Léotoing Laurent, Wittrant Yohann, Delzenne Nathalie M., Cani Patrice D., Neyrinck Audrey M., Meheust Agnes, Prebiotic effects: metabolic and health benefits, 10.1017/s0007114510003363
  5. Neyrinck Audrey M., Possemiers Sam, Druart Céline, Van de Wiele Tom, De Backer Fabienne, Cani Patrice D., Larondelle Yvan, Delzenne Nathalie M., Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice, 10.1371/journal.pone.0020944
  6. Everard Amandine, Lazarevic Vladimir, Derrien Muriel, Girard Myriam, Muccioli Giulio G., Neyrinck Audrey M., Possemiers Sam, Van Holle Ann, François Patrice, de Vos Willem M., Delzenne Nathalie M., Schrenzel Jacques, Cani Patrice D., Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice, 10.2337/db11-0227
  7. Druart C., Alligier M., Salazar N., Neyrinck A. M., Delzenne N. M., Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic Properties, 10.3945/an.114.005835
  8. Wanders Anne J., Feskens Edith J.M., Jonathan Melliana C., Schols Henk A., de Graaf Cees, Mars Monica, Pectin is not pectin: A randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake, 10.1016/j.physbeh.2014.02.007
  9. M Sanaka, Clin Exp Pharmacol Physiol, 34, 1151 (2007)
  10. Olano-Martin E., Gibson G.R., Rastall R.A., Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides, 10.1046/j.1365-2672.2002.01719.x
  11. Trompette Aurélien, Gollwitzer Eva S, Yadava Koshika, Sichelstiel Anke K, Sprenger Norbert, Ngom-Bru Catherine, Blanchard Carine, Junt Tobias, Nicod Laurent P, Harris Nicola L, Marsland Benjamin J, Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis, 10.1038/nm.3444
  12. Onumpai C., Kolida S., Bonnin E., Rastall R. A., Microbial Utilization and Selectivity of Pectin Fractions with Various Structures, 10.1128/aem.00179-11
  13. Bindels Laure B., Beck Raphaël, Schakman Olivier, Martin Jennifer C., De Backer Fabienne, Sohet Florence M., Dewulf Evelyne M., Pachikian Barbara D., Neyrinck Audrey M., Thissen Jean-Paul, Verrax Julien, Calderon Pedro Buc, Pot Bruno, Grangette Corinne, Cani Patrice D., Scott Karen P., Delzenne Nathalie M., Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model, 10.1371/journal.pone.0037971
  14. Dewys William D., Begg Colin, Lavin Philip T., Band Pierre R., Bennett John M., Bertino Joseph R., Cohen Martin H., Douglass Harold O., Engstrom Paul F., Ezdinli Ediz Z., Horton John, Johnson Gerhard J., Moertel Charles G., Oken Martin M., Perlia Charles, Rosenbaum Charles, Silverstein Murray N., Skeel Roland T., Sponzo Robert W., Tormey Douglass C., Prognostic effect of weight loss prior tochemotherapy in cancer patients, 10.1016/s0149-2918(05)80001-3
  15. J Sessions, J Manag Care Pharm, 13, 4 (2007)
  16. Moschovi Maria, Trimis Georgios, Vounatsou Maria, Katsibardi Katerina, Margeli Alexandra, Dimitriadi Filia, Papassotiriou Ioannis, Chrousos George, Tzortzatou-Stathopoulou Fotini, Serial Plasma Concentrations of PYY and Ghrelin During Chemotherapy in Children With Acute Lymphoblastic Leukemia : , 10.1097/mph.0b013e318179a1d8
  17. Fearon Kenneth, Arends Jann, Baracos Vickie, Understanding the mechanisms and treatment options in cancer cachexia, 10.1038/nrclinonc.2012.209
  18. Baracos Vickie E., Pichard Claude, Attaix Didier, Survival : the relevant primary outcome for nutrition therapy in cancer patients, 10.1097/mco.0b013e328352dc41
  19. Argilés Josep M., Busquets Sílvia, Stemmler Britta, López-Soriano Francisco J., Cancer cachexia: understanding the molecular basis, 10.1038/nrc3829
  20. Bindels L B, Porporato P, Dewulf E M, Verrax J, Neyrinck A M, Martin J C, Scott K P, Buc Calderon P, Feron O, Muccioli G G, Sonveaux P, Cani P D, Delzenne N M, Gut microbiota-derived propionate reduces cancer cell proliferation in the liver, 10.1038/bjc.2012.409
  21. Fiskus W., Pranpat M., Balasis M., Bali P., Estrella V., Kumaraswamy S., Rao R., Rocha K., Herger B., Lee F., Richon V., Bhalla K., Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate-Sensitive or Imatinib Mesylate-Resistant Chronic Myelogenous Leukemia Cells, 10.1158/1078-0432.ccr-06-0980
  22. Fiskus W., Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells, 10.1182/blood-2005-11-4639
  23. Salazar Nuria, Binetti Ana, Gueimonde Miguel, Alonso Ana, Garrido Pablo, González del Rey Carmen, González Celestino, Ruas-Madiedo Patricia, de los Reyes-Gavilán Clara G., Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats, 10.1016/j.ijfoodmicro.2010.10.016
  24. Neyrinck Audrey M., Possemiers Sam, Verstraete Willy, De Backer Fabienne, Cani Patrice D., Delzenne Nathalie M., Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin–glucan fiber improves host metabolic alterations induced by high-fat diet in mice, 10.1016/j.jnutbio.2010.10.008
  25. Druart Céline, Neyrinck Audrey M., Vlaeminck Bruno, Fievez Veerle, Cani Patrice D., Delzenne Nathalie M., Role of the Lower and Upper Intestine in the Production and Absorption of Gut Microbiota-Derived PUFA Metabolites, 10.1371/journal.pone.0087560
  26. Smith M. I., Yatsunenko T., Manary M. J., Trehan I., Mkakosya R., Cheng J., Kau A. L., Rich S. S., Concannon P., Mychaleckyj J. C., Liu J., Houpt E., Li J. V., Holmes E., Nicholson J., Knights D., Ursell L. K., Knight R., Gordon J. I., Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor, 10.1126/science.1229000
  27. Monira Shirajum, Nakamura Shota, Gotoh Kazuyoshi, Izutsu Kaori, Watanabe Haruo, Alam Nur Haque, Endtz Hubert Ph., Cravioto Alejandro, Ali Sk. Imran, Nakaya Takaaki, Horii Toshihiro, Iida Tetsuya, Alam Munirul, Gut Microbiota of Healthy and Malnourished Children in Bangladesh, 10.3389/fmicb.2011.00228
  28. Sheridan Paul O, Bindels Laure B, Saulnier Delphine M, Reid Gregor, Nova Esther, Holmgren Kerstin, O'Toole Paul W, Bunn James, Delzenne Nathalie, Scott Karen P, Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?, 10.4161/gmic.27252
  29. Leijdekkers Antonius G. M., Aguirre Marisol, Venema Koen, Bosch Guido, Gruppen Harry, Schols Henk A., In VitroFermentability of Sugar Beet Pulp Derived Oligosaccharides Using Human and Pig Fecal Inocula, 10.1021/jf4049676
  30. Bakir M. A., Bacteroides dorei sp. nov., isolated from human faeces, 10.1099/ijs.0.64257-0
  31. Ryan Karen K., Tremaroli Valentina, Clemmensen Christoffer, Kovatcheva-Datchary Petia, Myronovych Andriy, Karns Rebekah, Wilson-Pérez Hilary E., Sandoval Darleen A., Kohli Rohit, Bäckhed Fredrik, Seeley Randy J., FXR is a molecular target for the effects of vertical sleeve gastrectomy, 10.1038/nature13135
  32. Dewulf Evelyne M, Cani Patrice D, Claus Sandrine P, Fuentes Susana, Puylaert Philippe GB, Neyrinck Audrey M, Bindels Laure B, de Vos Willem M, Gibson Glenn R, Thissen Jean-Paul, Delzenne Nathalie M, Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women, 10.1136/gutjnl-2012-303304
  33. A Everard, ISME J (2014)
  34. Louis P., Scott K.P., Duncan S.H., Flint H.J., Understanding the effects of diet on bacterial metabolism in the large intestine, 10.1111/j.1365-2672.2007.03322.x
  35. Ge Hongfei, Li Xiaofan, Weiszmann Jennifer, Wang Ping, Baribault Helene, Chen Jin-Long, Tian Hui, Li Yang, Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids, 10.1210/en.2008-0059
  36. Das S. K., Eder S., Schauer S., Diwoky C., Temmel H., Guertl B., Gorkiewicz G., Tamilarasan K. P., Kumari P., Trauner M., Zimmermann R., Vesely P., Haemmerle G., Zechner R., Hoefler G., Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia, 10.1126/science.1198973
  37. Das Suman K., Hoefler Gerald, The role of triglyceride lipases in cancer associated cachexia, 10.1016/j.molmed.2013.02.006
  38. Cabassi Aderville, Tedeschi Stefano, Zinc-α2-glycoprotein as a marker of fat catabolism in humans : , 10.1097/mco.0b013e32835f816c
  39. Agustsson T., Ryden M., Hoffstedt J., van Harmelen V., Dicker A., Laurencikiene J., Isaksson B., Permert J., Arner P., Mechanism of Increased Lipolysis in Cancer Cachexia, 10.1158/0008-5472.can-06-4585
  40. C Druart, Br J Nutr, 1 (2013)
  41. Inoue Yusuke, Izawa Kiyoko, Tojo Arinobu, Nomura Yukihiro, Sekine Rieko, Oyaizu Naoki, Ohtomo Kuni, Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy, 10.1016/j.exphem.2006.11.006
  42. Peters D. G., Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia, 10.1182/blood.v97.5.1404